Fauci says vaccines for kids between 5-11 likely available in November
Send a link to a friend
[October 25, 2021]
By Humeyra Pamuk
WASHINGTON (Reuters) - Vaccines for kids
between the ages of 5 and 11 will likely be available in the first half
of November, top U.S. infectious disease expert Anthony Fauci said on
Sunday, predicting a timetable that could see many kids getting fully
vaccinated before the end of the year.
"If all goes well, and we get the regulatory approval and the
recommendation from the CDC, it's entirely possible if not very likely
that vaccines will be available for children from 5 to 11 within the
first week or two of November," Fauci said in an interview with ABC's
This Week.
U.S. Food and Drug Administration officials are reviewing the Pfizer/BioNTech
application seeking authorization of its 2-dose vaccine for younger
children, with its panel of outside advisers scheduled to weigh in on
Oct. 26.
The FDA typically follows the advice of its panel but is not required to
do so.
Advisers to the U.S. Centers for Disease Control and Prevention (CDC)
will weigh in on recommendations for the vaccine at a meeting on Nov. 2
and Nov. 3, helping to inform a final decision by its director.
CDC Director Rochelle Walensky, speaking at Fox News Sunday, also said
the agency wanted to act swiftly.
"After they (FDA) are able to review all the science and conduct the
regulatory action and the CDC will meet, and if all of that goes
smoothly ... we will act quickly," she said.
"We know how many parents are interested in getting their children
between 5 and 11 vaccinated and we intend to act as quickly as we can,"
she added.
[to top of second column]
|
Anthony Fauci, director of the National Institute of Allergy and
Infectious Diseases, speaks during a Senate Health, Education,
Labor, and Pensions Committee hearing at the Dirksen Senate Office
Building in Washington, D.C., U.S., July 20, 2021. Stefani
Reynolds/Pool via REUTERS
Once authorized, roughly 28 million more children in
the United States would be eligible to receive what would be the
first U.S. COVID-19 vaccine for younger kids. The Pfizer/BioNTech
shot is already available to those ages 12-17, and the companies are
still studying it for children younger than 5.
While children have a lower rate of death from COVID-19, many face
illness and long-term symptoms that are still being studied. Many
adults who have been hesitant or opposed to the COVID-19 vaccine,
and even some who did not oppose the vaccine for themselves, are
expected to resist giving the shot to their children.
Asked if schools should mandate a vaccine for kids, Walensky said:
"Right now we are at authorization. We're having discussions about
authorization. I think we need to get children vaccinated through
this authorization and get to approval before we can make a judgment
there."
(Reporting by Humeyra Pamuk; Editing by Mark Porter)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|